Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne 和 Regulus Therapeutics 宣佈繼續開展技術和臨床合作，此前 Regulus 對常染色體顯性遺傳性多囊腎病的 RGLS8429 進行了第二組 1B 期多重上升研究的頭條結果
Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne 和 Regulus Therapeutics 宣佈繼續開展技術和臨床合作，此前 Regulus 對常染色體顯性遺傳性多囊腎病的 RGLS8429 進行了第二組 1B 期多重上升研究的頭條結果
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。